Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Long-Term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: A Systematic Review and Meta-Analysis of 178 Population-Based Studies Publisher Pubmed



Mohammadian Khonsari N1 ; Shahrestanaki E2 ; Ejtahed HS3, 4 ; Djalalinia S5, 6 ; Sheidaei A7 ; Hakakzargar B8 ; Heshmati J9 ; Mahdavigorabi A10 ; Qorbani M10, 11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran
  2. 2. Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran
  3. 3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran
  6. 6. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada
  9. 9. Songhor Healthcare Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  10. 10. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  11. 11. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Current Hypertension Reports Published:2021


Abstract

Purpose of Review: This study investigated and pooled the long-term trends in prevalence, awareness, treatment, and control of hypertension (HTN) in the Middle East and North Africa (MENA) region. In this systematic review and meta-analysis, we searched MEDLINE/PubMed, Web of Science, Google Scholar, EMBASE, and Scopus between database inception and November 2020. All cross-sectional studies that investigated the prevalence of pre-HTN, HTN, awareness, treatment, and control in the MENA counties were included. The selection study, data extraction, and quality assessment were conducted by two investigators independently. Heterogeneity between studies was assessed using Cochran’s Q test and I-squared, and due to sever heterogeneity between studies, the random effect model was used to pool the estimates. Sensitivity analysis was performed to estimate the long-term trends in prevalence, awareness, treatment, and control rates of HTN according to definition of HTN as systolic blood pressure of 140 mm Hg or more, or diastolic blood pressure of 90 mm Hg or more, or being on pharmacological treatment for HTN. Recent Findings: Overall, 178 studies met the inclusion criteria. Studies comprised 2,262,797 participants with a mean age of 45.72 ± 8.84 years. According to random effect model, the pooled prevalence of pre-HTN and HTN was 33% (95% CI 28, 39) and 26% (25, 27), respectively. Over the past three decades, prevalence of hypertension increased significantly in the region. The pooled awareness, treatment, and control rates were 50% (48, 53), 41% (38, 44), and 19% (17, 21), receptively. The pooled awareness, treatment, and control rates of HTN were lower significantly in men than women. According to definition of HTN as blood pressures above 140/90 mm Hg, over the past three decades, although the awareness and treatment rates did not change significantly, the control rates improved significantly in the region. Summary: The findings showed that HTN is a significant public health problem in the MENA region. Although there are low levels of pooled awareness, treatment, and control rates, the control rates improved over the past three decades in the region. © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
28. The Profile of Rafsanjan Cohort Study, European Journal of Epidemiology (2021)
37. Direct Costs of Hypertension Treatment in Iran, Iranian Journal of Public Health (2023)
43. Iran in Transition, The Lancet (2019)